Lucila Garcia-Contreras to Mycobacterium tuberculosis
This is a "connection" page, showing publications Lucila Garcia-Contreras has written about Mycobacterium tuberculosis.
Connection Strength
1.502
-
SHetA2 Dry Powder Aerosols for Tuberculosis: Formulation, Design, and Optimization Using Quality by Design. Mol Pharm. 2018 01 02; 15(1):300-313.
Score: 0.583
-
Pharmacokinetics of sequential doses of capreomycin powder for inhalation in guinea pigs. Antimicrob Agents Chemother. 2012 May; 56(5):2612-8.
Score: 0.388
-
Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig. J Antimicrob Chemother. 2006 Nov; 58(5):980-6.
Score: 0.267
-
Liquid chromatographic determination of CPZEN-45, a novel anti-tubercular drug, in biological samples. J Pharm Biomed Anal. 2014 Jan; 88:370-6.
Score: 0.109
-
Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity. AAPS J. 2010 Sep; 12(3):338-47.
Score: 0.086
-
Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrob Agents Chemother. 2007 Aug; 51(8):2830-6.
Score: 0.070